These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Hyperammonia, hypoglycemia and thrombocytopenia in a newborn after materanl treatment with valproate]. Bruel H; Chabrolle JP; Amusini P; Levesque L; Iskandar K; Poinsot J Arch Pediatr; 2001 Apr; 8(4):446-7. PubMed ID: 11339140 [No Abstract] [Full Text] [Related]
24. Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Tohen M; Castillo J; Baldessarini RJ; Zarate C; Kando JC Am J Psychiatry; 1995 Mar; 152(3):413-8. PubMed ID: 7864268 [TBL] [Abstract][Full Text] [Related]
25. [Clinical irrelevance of the hematologic side effects of sodium valproate (Depakine)]. Loisseau P; Martínez-Lage JM Rev Med Univ Navarra; 1981 Sep; 25(3):14-6. PubMed ID: 6803320 [No Abstract] [Full Text] [Related]
26. Valproate-associated coagulopathies are frequent and variable in children. Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976 [TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital. Conley EL; Coley KC; Pollock BG; Dapos SV; Maxwell R; Branch RA Pharmacotherapy; 2001 Nov; 21(11):1325-30. PubMed ID: 11714204 [TBL] [Abstract][Full Text] [Related]
28. Predicting the occurrence of thrombocytopenia from free valproate levels: A prospective study. Nasreddine W; Atweh SF; Beydoun AA; Dirani M; Nawfal O; Beydoun A Seizure; 2022 Jan; 94():33-38. PubMed ID: 34864249 [TBL] [Abstract][Full Text] [Related]
29. Valproate-associated dysmyelopoiesis in elderly patients. So CC; Wong KF Am J Clin Pathol; 2002 Aug; 118(2):225-8. PubMed ID: 12162682 [TBL] [Abstract][Full Text] [Related]
33. Sodium valproate: its use in primary psychiatric disorders. McElroy SL; Keck PE; Pope HG J Clin Psychopharmacol; 1987 Feb; 7(1):16-24. PubMed ID: 3102563 [TBL] [Abstract][Full Text] [Related]
34. Role of valproate across the ages. Treatment of epilepsy in adults. Ben-Menachem E; Schmitz B; Tomson T; Vajda F Acta Neurol Scand Suppl; 2006; 184():14-27. PubMed ID: 16776493 [TBL] [Abstract][Full Text] [Related]
35. Evaluating the incidence of leukopenia and neutropenia with valproate, quetiapine, or the combination in children and adolescents. Rahman A; Mican LM; Fischer C; Campbell AH Ann Pharmacother; 2009 May; 43(5):822-30. PubMed ID: 19401471 [TBL] [Abstract][Full Text] [Related]
36. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls. Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528 [TBL] [Abstract][Full Text] [Related]